Even though IL-6 inhibitors could be useful in severe or critical COVID-19 patients, appropriate timing and dosage, monotherapy or combination therapy, and proper side effect management must be noticed regarding the clinical administration of these drugs, as IL-6 could either inhibit or increase viral replication and function [56]. Here, IL6 is linked to COVID-19.